At what enterprise value was CURAEOS acquired in 2021?

You can find the full valuation details of CURAEOS on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of CURAEOS when it was acquired by COLOSSEUM DENTAL GROUP?

The exact EV/EBITDA multiple for CURAEOS is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

When was CURAEOS acquired by COLOSSEUM DENTAL GROUP?

CURAEOS was acquired by COLOSSEUM DENTAL GROUP in 2021.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the CURAEOS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the CURAEOS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://jacobscap.com/wp-content/uploads/2025/11/202100802_CDG-Press-release_Curaeos_final_English.pdf

← DATABASE

Home Database Healthcare & PharmaCURAEOS

08/2021

CURAEOS acquired by COLOSSEUM DENTAL GROUP

NETHERLANDS Health Providers / Outpatient Care / Dental Centers REV 1m EUR - 100m EUR

Context

Colosseum Dental Group (CDG), a subsidiary of the Swiss-based Jacobs Holding, has successfully entered into a definitive agreement to acquire 100% of Curaeos. This transaction represents a transformative milestone in the group’s expansion strategy, creating the premier global dental services platform with approximately 800 clinics and over 13,000 professionals. The strategic rationale for the acquisition centers on the high degree of geographical complementarity between the two organizations, providing the group with immediate entry into the Belgian and Dutch markets while significantly densifying its existing leadership positions in Denmark, Italy, and Germany. By integrating the target’s scalable IT platform and vertically integrated laboratory network, the organization is poised to realize massive economies of scale and set new benchmarks for innovation within the European oral health sector. The partnership is designed to leverage combined medical and operational expertise to enhance patient care standards and professional development programs. This integration reinforces the organization's standing as a primary consolidator in the global healthcare landscape, providing the financial depth and strategic vision required to drive long-term value creation in non-cyclical, mission-critical service sectors.

CURAEOS, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Curaeos is a vertically integrated healthcare organization functioning as a multi-functional dental service platform across Northern and Western Europe. The entity’s business model is anchored by a centralized Shared Service Center (SSC) that manages HR, finance, administration, and procurement, effectively decoupling administrative burdens from clinical practice. Its value proposition is centered on providing a comprehensive range of general and specialist dental care through highly recognized brands such as DentConnect and DentalCoop. Strategically, the organization focuses on operational efficiency and a performance-oriented, client-centric culture, supported by a scalable IT infrastructure designed for rapid regional expansion. By integrating high-end dental clinics with professional laboratories, the firm ensures a seamless value chain for patients and practitioners alike. The organization facilitates the modernization of oral healthcare by prioritizing technical durability and clinical standardization across its multi-country network.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
10/2021	THE CRANEMERE GROUP	OUTPATIENT IMAGING AFFILIATES	UNITED STATES	Health Providers	Cranemere Group has acquired a majority stake in Outpatient Imaging Affiliates (OIA), a leading US provider of outpatient medical imaging services. This transaction strengthens Cranemere's presence in the healthcare sector by partnering with a prominent player in the diagnostic imaging market
09/2021	LIVINGBRIDGE	EVERLIGHT RADIOLOGY	UNITED KINGDOM	Health Providers	Livingbridge has announced the acquisition of a stake in Everlight Radiology, a world-renowned teleradiology provider, from Intermediate Capital Group (ICG), a global alternative asset manager. This secondary LBO transaction provides the technology-enabled healthcare platform with a new premier institutional sponsor to back its next international growth chapter
07/2021	EQT PARTNERS	MEINE RADIOLOGIE	GERMANY	Health Providers	The acquisition of Meine Radiologie Holding by EQT Infrastructure from Triton is a cornerstone transaction in the consolidation of the German outpatient imaging market. Occurring simultaneously with EQT’s acquisition of the Blikk Group from DBAG, the primary rationale for the deal is the merger of these two established entities into a single, market-leading radiology platform
07/2021	WREN HOUSE	ALMAVIVA SANTÉ	FRANCE	Health Providers	Wren House signed an agreement to acquire a controlling stake in Almaviva Santé from Antin Infrastructure Partners, which had initiated its exit process by mandating Rothschild & Co and Morgan Stanley as advisors following a refinancing earlier in 2021
07/2021	EQT PARTNERS	BLIKK GROUP	GERMANY	Health Providers	The acquisition of Blikk Group by EQT Infrastructure, occurring simultaneously with the buyout of Meine Radiologie Holding from Triton, is a landmark consolidation in the German healthcare services market
07/2021	OMERS	AMEDES	GERMANY	Health Providers	A consortium led by Goldman Sachs Asset Management and OMERS Infrastructure acquired amedes from Antin Infrastructure Partners. The transaction valued roughly doubling its value since Antin's entry in 2015
07/2021	CERBA HEALTHCARE	LIFEBRAIN	ITALY	Health Providers	Cerba HealthCare won a highly competitive auction process managed by Goldman Sachs and JP Morgan to acquire Lifebrain from Investindustrial. The transaction marks Cerba's entry as a major player in the Italian market, significantly expanding its European footprint
05/2021	INFRATIL	PACIFIC RADIOLOGY GROUP	NEW ZEALAND	Health Providers	Infratil acquired a majority stake in Pacific Radiology from its existing doctor shareholders. The remaining equity continues to be held by the group's doctors and management, maintaining a strong clinical alignment
04/2021	AMERICAN SECURITIES	SIMONMED IMAGING	UNITED STATES	Health Providers	SimonMed Imaging has entered into a strategic partnership with American Securities, a leading US private equity firm, as part of a growth investment aimed at supporting the company's next phase of expansion
04/2021	ICG / MANAGEMENT & PRIVATE INVESTORS	DOMUSVI	FRANCE	Health Providers	DomusVi completed a major capital reorganization, described as a "jumbo-LBO". This transaction allowed founder Yves Journel to increase his ownership from 30% to 49%, while ICG remains a key controlling partner

REFERENCES

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of CURAEOS by COLOSSEUM DENTAL GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: colosseum dental group